Persistence of Preleukemic Clonal Hematopoiesis after Chemotherapy is Associated with Poor Prognosis in Patients with High Risk MDS and AML. (April 2017) - Takahashi, K.; Wang, F.; Patel, K.; Bueso-Ramos, C.; Issa, G.; Song, X.; Zhang, J.; Little, L.; Gumbs, C.; Ravandi, F.; Kadia, T.; Daver, N.; et al.